Evaluation of interferon-gamma responses to HCMV infection in HIV positive individuals

Not Applicable

Completed

• Conditions: HIV; Infection - Acquired immune deficiency syndrome (AIDS / HIV)

• Registration Number: ACTRN12605000496617
• Lead Sponsor: Cellestis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

HIV positive with history of documented HCV infection.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate interferon responses to CMV in HIV positive individuals[]

Secondary Outcome Measures

Name	Time	Method
Will also look at the correlation between CD4 T cell numbers and HLA type with the interferon response.[]